AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

NZ sharemarket dips as big stocks weigh despite KMD gains
Markets

NZ sharemarket dips as big stocks weigh despite KMD gains

The NZ sharemarket closed down, although KMD Brands lifted on a positive result.

Investor days to test gentailer plans for new build and firming
Markets

Investor days to test gentailer plans for new build and firming

Investors want answers on build delays, capital plans and Huntly’s future.

Argosy delivers strong first-half results
Economy

Argosy delivers strong first-half results

Earnings and net tangible asset value per share up. 

Asset Plus' first-half profit lower as Munroe Lane in focus
Economy

Asset Plus' first-half profit lower as Munroe Lane in focus

First-half net tangible assets per share down on the year.